Regen Biopharma, Inc. Watch

from 10-Q 3 pages Neither the Issuance and Sale of the Securities Represented by This Certificate Nor the Securities Into Which These Securities Are Convertible Have Been Registered Under the Securities Act of 1933, as Amended, or Applicable State Securities Laws. the Securities May Not Be Offered for Sale, Sold, Transferred or Assigned (I) in the Absence of (A) an Effective Registration Statement for the Securities Under the Securities Act of 1933, as Amended, or (B) an Opinion of Counsel (Which Counsel Shall Be Selected by the Holder), in a Generally Acceptable Form, That Registration Is Not Required Under Said Act or (II) Unless Sold Pursuant to Rule 144 or Rule 144a Under Said Act. Notwithstanding the Foregoing, the Securities May Be Pledged in Connection With a Bona Fide Margin Account or Other Loan or Financing Arrangement Secured by the Securities. Principal Amount: US$114,000.00 Purchase Price: US$114,000.00 Issue Date: May 18, 2018 Convertible Promissory Note

from 10-Q 3 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and One (1) Share of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 2 Cents Per Unit.(each Unit Consists of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act 1

from 10-Q 4 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and One (1) Share of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act 1

from 10-Q 4 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and One (1) Share of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 2.5 Cents Per Unit.(each Unit Consists of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act 1

from 10-Q 2 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and One (1) Share of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 2.5 Cents Per Unit.(each Unit Consists of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act 1

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of Four (4) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of Four (4)shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of Four (4) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of Four (4)shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and Three (3) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of One (1) Share of Common Stock of the Company and Three (3) Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and Three (3) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of One (1) Share of Common Stock of the Company and Three (3) Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and Three (1) Share of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and Three (1) Share of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and Three (1) Share of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-K ~5 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One (1) Share of Common Stock of the Company and Three (1) Share of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of One (1) Share of Common Stock of the Company and One (1) Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-Q 4 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of Two ( 2) Shares of the Common Stock of the Company and One (1) Share of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 15 Cents Per Unit.(each Unit Consists of Two Shares of Common and One Share of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-Q 4 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One ( 1) Shares of the Common Stock of the Company and Three (3) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of One Share of Common and Three Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act

from 10-Q 4 pages This Unit Purchase Agreement (The “Agreement”) Is Entered Into by and Among Regen Biopharma, Inc., a Nevada Corporation (The “Company”) Whose Address Is 4700 Spring Street, St 304, La Mesa, California 91942 and ( “Purchaser”), a Whose Address Is . Whereas: The Purchaser Desires to Purchase Units (“Units”) of Securities of the Company in Accordance With the Terms and Conditions Set Forth Herein. the Company Desires to Issue and Sell Units to the Purchaser in Accordance With the Terms and Conditions Set Forth Herein. Therefore, It Is Agreed as Follows 1. Units Each Unit Shall Consist of One ( 1) Shares of the Common Stock of the Company and Three (3) Shares of the Series a Preferred Stock of the Company 2. Purchase Price the Purchase Price Per Unit ( “Purchase Price”), Payable in US Dollars, Shall Be 5 Cents Per Unit.(each Unit Consists of One Share of Common and Three Shares of the Series a Preferred Stock of the Company) 3. Form of Payment the Purchaser Shall Pay the Purchase Price Per Unit Multiplied by That Number of Units Purchased by Wire Transfer of Immediately Available Funds to the Company Wire Instructions: 4. Issuance of Units 5 Business Days Subsequent to Receipt of Payment of the Purchase Price the Company Shall Issue to the Purchaser That Number of Units Purchased 5. Purchaser’s Representations and Warranties (A) as of the Date Hereof, the Purchaser Is Purchasing the Units for Its Own Account and Not With a Present View Towards the Public Sale or Distribution Thereof, Except Pursuant to Sales Registered or Exempted From Registration Under the Securities Act of 1933, as Amended ( the “Act”). (B) the Purchaser Is an “Accredited Investor” as That Term Is Defined in Rule 501(a) of Regulation D Promulgated Under the Act